Manuscripts
Showing 1494 manuscripts.
Safety, Tolerability, and Pharmacokinetics of a Long-Acting Broadly Neutralizing Human Immunodeficiency Virus Type 1 (HIV-1) Monoclonal Antibody VRC01LS in HIV-1-Exposed Newborn Infants
Citation
Elizabeth McFarland, Coleen Cunningham, Petronella Muresan, Edmund Capperelli, Charlotte Perlowski, Patricia Morgan, Betsy Smith, Rohan Hazra, Lynette Purdue, Paul Harding, Gerhard Theron, Hilda Mujuru, Allison Agwu, Murli Purswani, Mobeen Rathore, Britta Flach, Alison Taylor, Bob Lin, Adrian McDermott, John Mascola, Barney Graham, IMPAACT P1112 Team. Safety, Tolerability, and Pharmacokinetics of a Long-Acting Broadly Neutralizing Human Immunodeficiency Virus Type 1 (HIV-1) Monoclonal Antibody VRC01LS in HIV-1-Exposed Newborn Infants. Journal of Infectious Diseases. 2021. 224: 1916-1924. PMID: 34009371Journal
Journal of Infectious Diseases
Study
P1112
Ethically designing research to inform multidimensional, rapidly evolving policy decisions: Lessons learned from the PROMISE HIV Perinatal Prevention Trial
Citation
Seema K. Shah, Alex John London, Lynne Mofenson, James V. Lavery, Grace John-Stewart, Patricia Flynn, Gerhard Theron, Shrikhant I. Bangdiwala, Dhayendre Moodley, Lameck Chinula, Lee Fairlie, Tumalano Sekoto, Tebogo J. Kakhu, Avy Violari, Sufia Dadabhai, Katie McCarthy, Mary Glenn Fowler. Ethically designing research to inform multidimensional, rapidly evolving policy decisions: Lessons learned from the PROMISE HIV Perinatal Prevention Trial. SAGE Publications: Society for Clinical Trials. 2021. PMID: 34524048Journal
SAGE Publications: Society for Clinical Trials
Study
1077BF
Effects of Pregnancy and Isoniazid Preventive Therapy on Mycobacterium tuberculosis Interferon Gamma Response Assays in Women with HIV
Citation
Adriana Weinberg, Lisa Aaron, Grace Montepiedra, Timothy Sterling, Renee Browning, Blandina Mmbaga, Tichaona Vhembo, Shilpa Naik, Enid Kabugho, Gaerolwe Masheto, Savita Pahwa, Jyoti Mathad, Sylvia LaCourse, Katie McCarthy, Sarah Bradford, Gerhard Theron, Diane Costello, Bonnie Zimmer, Marie Flores Pierre, Kamunkhwala Gausi, Paolo Denti, David Haas, Amita Gupta, IMPAACT P1078 Study Team. Effects of Pregnancy and Isoniazid Preventive Therapy on Mycobacterium tuberculosis Interferon Gamma Response Assays in Women with HIV. Clinical Infectious Diseases. 2021. 73: e3555-e3562. PMID: 32720695Journal
Clinical Infectious Diseases
Study
P1078
Tenofovir diphosphate concentrations in dried blood spots from pregnant and postpartum adolescent and young women receiving daily observed pre-exposure prophylaxis in sub-Saharan Africa
Citation
Lynda Stranix-Chibanda, Peter L Anderson, Deborah Kacanek, Sybil Hosek, Sharon Huang, Teacler G Nematadzira, Frank Taulo, Violet Korutaro, Clemensia Nakabiito, Maysebole Masenya , Kathryn Lypen , Emily Brown, Mustafa E Ibrahim, Jenna Yager, Lubbe Wiesner, Benjamin Johnston, K Rivet Amico , James F Rooney , Nahida Chakhtoura, Hans M L Spiegel, Benjamin H Chi, IMPAACT 2009 team. Tenofovir diphosphate concentrations in dried blood spots from pregnant and postpartum adolescent and young women receiving daily observed pre-exposure prophylaxis in sub-Saharan Africa. Clinical Infectious Diseases. 2021. PMID: 33341883Journal
Clinical Infectious Diseases
Study
IMPAACT 2009
Effect on growth of exposure to maternal antiretroviral therapy in breastmilk versus extended infant nevirapine prophylaxis among HIV-exposed perinatally uninfected infants in the PROMISE randomized trial
Citation
Lynda Stranix-Chibanda, Camlin Tierney, Mauricio Pinilla, Kathleen George, Jim Aizire, Godwin Chipoka, Macpherson Mallewa, Megeshinee Naidoo, Teacler Nematadzira, Bangani Kusakara, Avy Violari, Tapiwa Mbengeranwa, Boniface Njau, Lee Fairlie, Gerard Theron, Mwangelwa Mubiana-Mbewe, Sandhya Khadse, Renee Browning, Mary Glenn Fowler, George K. Siberry. Effect on growth of exposure to maternal antiretroviral therapy in breastmilk versus extended infant nevirapine prophylaxis among HIV-exposed perinatally uninfected infants in the PROMISE randomized trial. PLoS One. 2021. 16: e0255250.Journal
PLoS One
Study
P1084s
Using a composite maternal-infant outcome measure in tuberculosis prevention studies among pregnant women
Citation
Grace Montepiedra, Soyeon Kim, Adriana Weinberg, Gerhard Theron, Timothy R Sterling, Sylvia M LaCourse, Sarah Bradford, Nahida Chakhtoura, Patrick Jean-Philippe, Scott Evans, Amita Gupta. Using a composite maternal-infant outcome measure in tuberculosis prevention studies among pregnant women. Clinical Infectious Diseases. 2021. PMID: 33146706Year
2022
Journal
Clinical Infectious Diseases
Study
P1078
Individual and Composite Adverse Pregnancy Outcomes in a Randomized Trial on Isoniazid Preventative Therapy Among Women Living With HIV
Citation
Gerhard Theron, Grace Montepiedra, Lisa Aaron, Katie McCarthy, Chakhtoura Nahida, Patrick Jean-Philippe, Bonnie Zimmer, Amy James Loftis, Tsungai Chipato, Teacler Nematadzira, Mandisa Nyati, Carolyne Onyango-Makumbi, Gaerolwe Masheto, James Ngocho, Fuanglada Tongprasert, Sandesh Patil, Dominique Lespinasse, Adriana Weinberg, Amita Gupta, IMPAACT P1078 TB APPRISE Study Team. Individual and Composite Adverse Pregnancy Outcomes in a Randomized Trial on Isoniazid Preventative Therapy Among Women Living With HIV. Clinical Infectious Diseases. 2021. PMID: 32997744Year
2022
Journal
Clinical Infectious Diseases
Study
P1078
IMPAACT 2016: Operationalizing HIV Intervention Adaptations to Inform the Science and Outcomes of
Implementation
Citation
Jennifer Libous, Nicole A. MontaƱez, Geri R. Donenberg, Dorothy E. Dow, Suad Kapetanovic, Janice Buckley, Tebogo Jacqueline Kakhu, Portia Kamthunzi, Limbika A. Maliwichi, Tichaona Vhembo, Tariro Dianah Chawana, Teacler Nematadzira. IMPAACT 2016: Operationalizing HIV Intervention Adaptations to Inform the Science and Outcomes of Implementation. Frontiers in Reproductive Health. 2021. 3: 1-9. PMID: 36303985Year
2021
Journal
Frontiers in Reproductive Health
Study
IMPAACT 2016
Pharmacokinetics and Safety of Zidovudine, Lamivudine, and Lopinavir/Ritonavir in HIV-infected Children With Severe Acute Malnutrition in Sub-Saharan Africa: IMPAACT Protocol P1092
Citation
Maxensia Owor, Camlin Tierney, Lauren Ziemba, Renee Browning, John Moye, Bobbie Graham, Christina Reding, Diane Costello, Jennifer Norman, Lubbe Wiesner, Emma Hughes, Meghan E. Whalen, Lynette Purdue, Blandina Theophil Mmbaga, Portia Kamthunzi, Rachel Kawalazira, Kusum Nathoo, Sarah Bradford, Anne Coletti, Francesca Aweeka, Philippa Musoke. Pharmacokinetics and Safety of Zidovudine, Lamivudine, and Lopinavir/Ritonavir in HIV-infected Children With Severe Acute Malnutrition in Sub-Saharan Africa: IMPAACT Protocol P1092. Pediatric Infectious Disease Journal. 2021. PMID: 33464021Journal
Pediatric Infectious Disease Journal
Study
P1092
SARS-CoV-2, SARS-CoV-1, and HIV-1 derived ssRNA sequences activate the NLRP3 inflammasome in human macrophages through a non-classical pathway.
Citation
Campbell GR, To RK, Hanna J, Spector SA. SARS-CoV-2, SARS-CoV-1, and HIV-1 derived ssRNA sequences activate the NLRP3 inflammasome in human macrophages through a non-classical pathway.. iScience. 2021. 24: 102295. PMID: 33718825Journal
iScience